Systematic Approach to Biopsy Interpretation in Anatomical Pathology

Overview

Accurate biopsy interpretation is a structured cognitive process beginning before the pathologist views any slide. A disciplined, stepwise approach minimises diagnostic error, ensures minimum diagnostic criteria are met, and enables appropriate communication of uncertainty when ancillary testing or additional material is required. This framework applies across all organ systems and specimen types.

Pre-Microscopy Review: Orientation, Specimen Type, and Clinical Context

Clinical Information Review

Clinical context critically shapes pattern recognition. Linear IgG staining along the glomerular basement membrane carries entirely different significance in a young patient with haematuria and renal failure (anti-GBM disease) versus an elderly patient with diabetes (non-specific trapping in diabetic glomerulosclerosis - not indicative of anti-GBM antibodies). Apoptotic bodies in colonic crypts may represent graft-versus-host disease in a bone marrow transplant recipient, or simply reflect oral sodium phosphate bowel preparation effect - a distinction that is impossible without knowing the clinical context.

Specimen Triage and Fixative Verification

The pathologist must confirm that the correct fixative or transport medium was used for each intended modality:

Incorrect triage is irreversible. A renal biopsy placed entirely in formalin cannot subsequently be used for immunofluorescence. Where multiple modalities are needed, the specimen must be divided appropriately at triage, with histology taking priority if no prior diagnosis exists.

Specimen Adequacy

Adequacy assessment must occur before rendering a diagnosis:

• A single glomerulus may suffice for diffusely distributed diseases with characteristic morphology (e.g., amyloidosis, membranous glomerulonephritis)
• ≥8-10 glomeruli are generally required for class assignment in most glomerular diseases
• ≥20 glomeruli are required for reliable focal/diffuse distinction and accurate classification in lupus nephritis
• For temporal artery biopsy, the specimen should be 1-3 cm in length, sampled at multiple levels, given the segmental distribution of giant cell arteritis (GCA); diagnostic sensitivity is reduced by prior corticosteroid treatment
• For endomyocardial biopsy, a minimum of 3-5 fragments should be submitted; all pieces should be embedded in the same block, with at least 3 slides sectioned at 4-5 µm from different depths
• For small bowel biopsy, 4-6 endoscopic specimens should be obtained; optimal evaluation requires a well-oriented section including muscularis mucosae and a small portion of upper submucosa; step sectioning (3-7 levels) with H&E and Alcian blue/PAS is standard
• For skin biopsy, perpendicular ("on edge") embedding with 5 levels is standard; a separate fragment in Michel's medium is required for immunofluorescence if a blistering disorder or vasculitis is suspected

Gross Examination Before Microscopy

Even small biopsies warrant macroscopic assessment: - Number, size, and integrity of cores or fragments - Colour and texture (haemorrhagic, pale, mucoid, gritty) - Visible lesions, necrosis, or calcification - Adequacy of margins (excision specimens: ink all margins before bread-loafing)

Pattern Recognition: Architectural vs Cytological Abnormalities

A two-tier assessment - architectural first, then cytological - provides a reproducible scaffold regardless of organ system.

Architectural Assessment (Low Power: ×2-×10)

Always begin at scanning/low magnification. Low-power pattern recognition narrows the differential before high-power examination is applied.

Identifying an MPGN pattern by LM immediately requires immunofluorescence (to distinguish immune complex-mediated disease from C3 glomerulopathy) and electron microscopy (to subtype as type I, dense deposit disease/type II, type IIIB, or type IIIS/A). Similarly, identifying crescentic GN by LM is only the beginning: immunofluorescence categorises the disease as anti-GBM (linear IgG), immune complex (granular), or pauci-immune (negative/trace), which has direct and urgent therapeutic implications.

Cytological Assessment (High Power: ×40)

After establishing the architectural pattern:

• Nuclear size, shape, chromatin pattern, nucleoli
• Cytoplasmic features (pale, granular, vacuolated, abundant, clear)
• Mitotic rate and abnormal mitoses
• Cell borders
• Intracellular inclusions or deposits
• Organ-specific cytological changes: podocyte foot process effacement, tubular injury pattern, endothelial swelling, myocyte vacuolation (e.g., anthracycline cardiotoxicity), viral cytopathic effect

This two-step approach prevents premature focus on cytological detail at the expense of missing critical architectural information.

Special Stains: Targeted Selection Based on Pattern

Special stains should be selected based on the LM pattern identified, not applied reflexively:

Minimum Diagnostic Criteria

Principles

• A definitive diagnosis should only be rendered when morphological findings, in the context of clinical information, meet accepted thresholds for that entity
• Semiquantitative reporting (proportion of glomeruli involved, degree of interstitial fibrosis, percentage of crescents) forces comprehensive examination of all histological compartments and improves reproducibility between pathologists and institutions
• Each renal biopsy report should include: number of glomeruli; number with specific lesions; mesangial matrix and cellularity assessment; endocapillary, mesangial, and extracapillary zone cellularity; proportion of interstitial inflammatory infiltrate, interstitial fibrosis, and tubular atrophy; distribution and intensity of immune deposits
• When criteria are not met, the pathologist must describe findings, list the differential, state what additional material or testing is required, and provide a qualified interpretation

Organ-Specific Minimum Criteria

Rendering a Descriptive Diagnosis When Classification Is Deferred

When to Use a Descriptive (Qualified) Diagnosis

• Tissue is too limited or poorly oriented for definitive classification
• Ancillary testing (IF, EM, IHC, molecular studies, flow cytometry) is pending or has not been performed
• Findings represent a pattern attributable to multiple aetiologies
• A poorly differentiated neoplasm cannot be lineage-assigned on morphology alone
• EM sampling is insufficient to characterise deposits representative of the whole biopsy

Structure of a Descriptive Report

1. Specimen adequacy statement - cores, glomeruli, fragments; orientation quality
2. Descriptive findings - all compartments assessed systematically; quantitative/semiquantitative data where applicable
3. Pattern identification - the LM pattern (e.g., "MPGN pattern on LM", "membranous pattern", "poorly differentiated neoplasm")
4. Differential diagnosis - ranked by probability given clinical and morphological context
5. Ancillary testing required - specific tests and their diagnostic purpose
6. Qualified interpretive comment - e.g., "The morphological findings are consistent with a diagnosis of X, pending immunofluorescence and electron microscopy"

Integration of Ancillary Testing Results

Sequential Multimodal Integration

In complex specimens - particularly renal biopsies - findings from LM, IF, and EM must be integrated by the same pathologist, as each modality provides complementary and sometimes discordant information. EM samples only a small fraction of the biopsy; observations should be extrapolated to the whole specimen cautiously and always interpreted within the LM and IF context.

The correlation between IF and EM findings is clinically significant: in ANCA-associated crescentic GN, when IF shows no immunoglobulin staining, immune complex-type EM deposits are present in fewer than 5% of cases; when IF shows ≥2+ immunoglobulin, EM deposits are present in the majority. Apparent discordance (e.g., IF-negative but EM deposits present) should prompt consideration of technical IF failure and may warrant IHC on paraffin sections as an alternative.

Updating the Diagnosis After Ancillary Results

When ancillary results become available, the initial descriptive diagnosis should be formally amended or a supplementary report issued. Any discordance between morphological and ancillary findings must be explicitly reconciled.

Diagnostic Pitfalls in Systematic Biopsy Interpretation